LCM
Lakewood Capital Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-18,100
| Closed | -$2.89M | – | 59 |
|
|
2021
Q3 | $2.89M | Sell |
18,100
-59,350
| -77% | -$9.46M | 0.13% | 55 |
|
|
2021
Q2 | $10.2M | Sell |
77,450
-4,000
| -5% | -$526K | 0.42% | 45 |
|
|
2021
Q1 | $10.5M | Sell |
81,450
-14,000
| -15% | -$1.8M | 0.45% | 42 |
|
|
2020
Q4 | $15.9M | Sell |
95,450
-20,000
| -17% | -$3.34M | 0.75% | 36 |
|
|
2020
Q3 | $17.8M | Sell |
115,450
-15,000
| -11% | -$2.31M | 0.86% | 38 |
|
|
2020
Q2 | $19.3M | Sell |
130,450
-20,000
| -13% | -$2.96M | 0.83% | 37 |
|
|
2020
Q1 | $16.9M | Sell |
150,450
-120,000
| -44% | -$13.5M | 0.77% | 33 |
|
|
2019
Q4 | $37.6M | Sell |
270,450
-40,000
| -13% | -$5.56M | 1.33% | 23 |
|
|
2019
Q3 | $29.9M | Sell |
310,450
-457,743
| -60% | -$44.1M | 1.02% | 23 |
|
|
2019
Q2 | $88.5M | Sell |
768,193
-240,000
| -24% | -$27.6M | 2.7% | 14 |
|
|
2019
Q1 | $119M | Buy |
1,008,193
+198,600
| +25% | +$23.4M | 3.33% | 13 |
|
|
2018
Q4 | $50.7M | Buy |
809,593
+23,100
| +3% | +$1.45M | 1.67% | 19 |
|
|
2018
Q3 | $55.7M | Buy |
786,493
+335,967
| +75% | +$23.8M | 1.84% | 19 |
|
|
2018
Q2 | $30M | Buy |
+450,526
| New | +$30M | 0.99% | 22 |
|